Miklos M Mozes
Overview
Explore the profile of Miklos M Mozes including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
294
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Stepanova G, Manzeger A, Mozes M, Kokeny G
Int J Mol Sci
. 2024 Dec;
25(23).
PMID: 39684261
Kidney fibrosis is a hallmark of chronic kidney diseases. Evidence shows that genetic variability and complement component 3 (C3) might influence tubulointerstitial fibrosis. Still, the role of renal C3 production...
2.
Manzeger A, Garmaa G, Mozes M, Hansmann G, Kokeny G
Int J Mol Sci
. 2023 Nov;
24(21).
PMID: 37958504
Excessive renal TGF-β production and pro-fibrotic miRNAs are important drivers of kidney fibrosis that lack any efficient treatment. Dysfunctional autophagy might play an important role in the pathogenesis. We aimed...
3.
Kokeny G, Nemeth A, Kopp J, Chen W, Oler A, Manzeger A, et al.
Kidney Int
. 2022 May;
102(2):337-354.
PMID: 35513123
Patients with chronic kidney disease and experimental animal models of kidney fibrosis manifest diverse progression rates. Genetic susceptibility may contribute to this diversity, but the causes remain largely unknown. We...
4.
Kokeny G, Calvier L, Legchenko E, Chouvarine P, Mozes M, Hansmann G
Curr Opin Nephrol Hypertens
. 2019 Dec;
29(2):171-179.
PMID: 31815758
Purpose Of Review: Pulmonary arterial hypertension (PAH) is characterized by pulmonary arterial endothelial cell (PAEC) dysfunction and apoptosis, pulmonary arterial smooth muscle cell (PASMC) proliferation, inflammation, vasoconstriction, and metabolic disturbances...
5.
Nemeth A, Mozes M, Calvier L, Hansmann G, Kokeny G
BMC Nephrol
. 2019 Jul;
20(1):245.
PMID: 31277592
Background: It has been proposed that peroxisome proliferator-activated receptor-γ (PPARγ) agonists might reduce renal fibrosis, however, several studies had contradictory results. Moreover, the possible interaction of TGF-β, PPARγ, and transcription...
6.
Calvier L, Chouvarine P, Legchenko E, Kokeny G, Mozes M, Hansmann G
Am J Respir Cell Mol Biol
. 2019 Jul;
61(1):121-123.
PMID: 31259625
No abstract available.
7.
Gasparics A, Kokeny G, Fintha A, Bencs R, Mozes M, Agoston E, et al.
Pathol Oncol Res
. 2017 Aug;
24(3):641-651.
PMID: 28815470
Suppressor of cancer cell invasion (SCAI) has been originally characterized as a tumor suppressor inhibiting metastasis in different human cancer cells, and it has been suggested that SCAI expression declines...
8.
Mozes M, Szoleczky P, Rosivall L, Kokeny G
BMC Nephrol
. 2017 Jul;
18(1):209.
PMID: 28673338
Background: Although TGF-ß and the transcription factor Egr-1 play an important role in both kidney fibrosis and in response to acute changes of renal medullary osmolarity, their role under sustained...
9.
Calvier L, Chouvarine P, Legchenko E, Hoffmann N, Geldner J, Borchert P, et al.
Cell Metab
. 2017 May;
25(5):1118-1134.e7.
PMID: 28467929
BMP2 and TGFβ1 are functional antagonists of pathological remodeling in the arteries, heart, and lung; however, the mechanisms in VSMCs, and their disturbance in pulmonary arterial hypertension (PAH), are unclear....
10.
Kokeny G, Fang L, Revesz C, Mozes M, Voros P, Szenasi G, et al.
Kidney Blood Press Res
. 2017 Mar;
42(1):109-122.
PMID: 28359068
Background/aims: Diabetic nephropathy remains a major clinical problem. The effects of prorenin might be adverse, but the literature data are controversial. We compared the renal effects of the (pro)renin receptor...